6-(3-METHYLPHENOXY)-4-((1-METHYL-1H-1,2,4-TRIAZOL-3-YL)METHOXY)-1-((2,4,5-TRIFLUOROPHENYL)METHYL)-1,3,5-TRIAZIN-2(1H)-ONE
UNII HG8CC9BHE8
Substance Identification & Data
This profile provides standardized clinical and technical data for 6-(3-methylphenoxy)-4-((1-methyl-1h-1,2,4-triazol-3-yl)methoxy)-1-((2,4,5-trifluorophenyl)methyl)-1,3,5-triazin-2(1h)-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HG8CC9BHE8.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2917584-96-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H17F3N6O3 BUXKCTQCBHPCNA-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6-(3-methylphenoxy)-4-((1-methyl-1h-1,2,4-triazol-3-yl)methoxy)-1-((2,4,5-trifluorophenyl)methyl)-1,3,5-triazin-2(1h)-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.